1. ORY‐1001, a KDM1A inhibitor, inhibits proliferation, and promotes apoptosis of triple negative breast cancer cells by inactivating androgen receptor. Issue 1 (4th August 2021) Authors: Wang, Tian; Zhang, Fulin; Sun, Fulan Journal: Drug development research Issue: Volume 83:Issue 1(2022) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗